secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2023-07-18T23:59:59+00:00
Accession:  0001104659-23-082006
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sagimet Biosciences closes IPO; files amended charter and bylaws effective July 18, 2023
--------------------------------------------------------------------------------

- Authorized 500M shares of Series A common stock and 15M shares of Series B common stock.
- Reclassified outstanding common stock as Series A common stock upon IPO closing.
- Charter authorizes 10M shares of undesignated preferred stock issuable in series by Board.
- Bylaws eliminate stockholder action by written consent and set procedures for proposals and director nominations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465923082006/0001104659-23-082006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465923082006/tm237052d22_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-082006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer